Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment

Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment

Glioblastoma remains the most common and aggressive primary brain tumor today. Because of the neuroanatomical location of glioblastoma, conventional chemotherapy and radiation therapy have limited efficacy in patients with these tumors. Over the past decade, antitumor immunotherapy has become widesp...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Timofeeva, A. O. Sitkovskaya, I. A. Novikova, M. A. Ezhova, E. P. Lysenko, O. I. Kit
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-06-01
Series:Медицинская иммунология
Subjects:
car-t-терапия
глиобластома
клинические испытания
il-13r α2
her2
egfrviii
Online Access:https://www.mimmun.ru/mimmun/article/view/2111
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items